August 13, 2002 article Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy The Journal of Gene Medicine DOI: 10.1002/jgm.295 OpenAlex Authors 0 Author list not loaded yet. Cited by 3 stored of 140 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Antisense-mediated exon skipping therapy improves neuromuscular junction deficits in a Duchenne muscular dystrophy mouse model 2025 Neuromuscular Disorders article Biochemistry, Genetics and Molecular Biology Muscle Physiology and Disorders Open access 1 citations Next Generation Exon 51 Skipping Antisense Oligonucleotides for Duchenne Muscular Dystrophy 2023 Nucleic Acid Therapeutics article Biochemistry, Genetics and Molecular Biology Muscle Physiology and Disorders Open access cited by 1 patent 19 citations 7′,5′-alpha-bicyclo-DNA: new chemistry for oligonucleotide exon splicing modulation therapy 2021 Nucleic Acids Research article Biochemistry, Genetics and Molecular Biology DNA and Nucleic Acid Chemistry Open access 11 citations 3 results References 0